15 Mar 2018 - 15 Mar 2018
Kymab's Director of Pharmacology and Translational Sciences, Richard Sainson will be presenting at the Crown Bioscience Symposium
This year the annual UK Oncology Drug Discovery symposium focuses on immuno-oncology and future advances in cancer treatment.
Immuno-oncology has revolutionised cancer research, with many novel agents already clinically approved. With continued enhancement of preclinical models and methods, the next generation of immunotherapeutics including combination therapies and new modalities can continue to bring patient benefits.
The symposium will bring together oncology and immuno-oncology R&D and preclinical teams from industry, academia, and medical research to facilitate cross discipline discussions on current techniques, and how to move forward with future approaches.